ATP1A2 and Cognitive impairment: Individuals with ATP1A2/ Na/K ATPase α2 mutations often exhibit cognitive impairments, ataxia, sensory disturbances, and seizures (Bottger et al, 2016; Isaksen and Lykke-Hartmann, 2016).